南方医科大学学报 ›› 2025, Vol. 45 ›› Issue (7): 1506-1512.doi: 10.12122/j.issn.1673-4254.2025.07.17

• • 上一篇    下一篇

柴胡疏肝汤通过上调ASIC1蛋白调节NMDAR通道改善大鼠癫痫后的认知障碍

于云红1(), 谢炜2, 李慧1   

  1. 1.广东省人民医院//广东省医学科学院//广东省老年医学研究所//南方医科大学,广东 广州 510080
    2.南方医科大学中医药学院,广东 广州 510515
  • 收稿日期:2024-08-07 出版日期:2025-07-20 发布日期:2025-07-17
  • 通讯作者: 于云红 E-mail:yuyunhong123@126.com
  • 基金资助:
    国家自然科学基金青年基金(81503564);广东省基础与应用基础研究基金项目(2019A1515011301);广东省中医药管理局项目(20231004)

Chaihu Shugan Decoction improves cognitive impairment after epilepsy in rats by regulating hippocampal NMDAR subunits via upregulating ASIC1

Yunhong YU1(), Wei XIE2, Hui LI1   

  1. 1.Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Institute of Guangdong Geriatric, Southern Medical University, Guangzhou 510080, China
    2.School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China
  • Received:2024-08-07 Online:2025-07-20 Published:2025-07-17
  • Contact: Yunhong YU E-mail:yuyunhong123@126.com
  • Supported by:
    Natural Science Foundation for the Youth (NSFY) of China(81503564)

摘要:

目的 探讨柴胡疏肝汤对氯化锂-匹罗卡品诱导癫痫后认知障碍大鼠认知功能损害的改善作用。 方法 SPF级雄性SD大鼠腹腔注射氯化锂-匹罗卡品诱导癫痫后认知障碍模型,空白对照组大鼠腹腔注射生理盐水。将癫痫后认知障碍大鼠随机分为:模型组(生理盐水)、阳性对照组(Donepezil,90 mg·kg-1·d-1)、柴胡疏肝汤1组(CHSG-1,2.5 g·kg-1·d-1)、柴胡疏肝汤2组(CHSG-2,5 g·kg-1·d-1)、柴胡疏肝汤3组(CHSG-3,10 g·kg-1·d-1)、柴胡疏肝汤4组(CHSG-4,20 g·kg-1·d-1)、柴胡疏肝汤5组(CHSG-5,40 g·kg-1·d-1),空白组大鼠(n=12)以生理盐水灌胃给药,各组大鼠连续灌胃给药4周后,Morris水迷宫观察各组大鼠认知行为变化,Western blotting检测大鼠海马区ASIC1、NR1、NR2A、NR2B蛋白表达水平,荧光定量PCR检测大鼠海马区 ASIC1、NR1、NR2A、NR2B的mRNA表达水平。 结果 柴胡疏肝汤治疗4周后,Morris水迷宫认知行为学结果显示,与模型组相比,CHSG-2和CHSG-3组大鼠逃避潜伏期缩短(P<0.05,P<0.01),CHSG-2和CHSG-3组大鼠目标象限停留时间延长(P<0.05),CHSG-2和CHSG-3组大鼠穿越平台次数增加(P<0.05);Western blotting结果显示,CHSG-2和CHSG-3组大鼠海马区ASIC1、NR1、NR2A、NR2B蛋白表达增加(P<0.05),与CHSG-3相比较,CHSG-1、CHSG-4和CHSG-5组蛋白表达降低(P<0.01)。PCR结果显示,与模型组相比较,CHSG-2组、CHSG-3组、CHSG-4组及CHSG-5组大鼠海马区ASIC1、NR1、NR2A、NR2B mRNA表达增加(P<0.05)。 结论 柴胡疏肝汤对癫痫后认知功能损害有一定的治疗作用,可能通过上调ASIC1通道蛋白进而调节抗N-甲基-D-天冬氨酸受体蛋白及亚单位蛋白及基因的表达及通道活性,调节神经元兴奋性及突触可塑性发挥治疗作用;柴胡疏肝汤的治疗作用在一定的剂量范围内显示剂量依赖性,且剂量浓度有一定的安全范围。

关键词: 癫痫, 认知障碍, 从肝论治, 柴胡疏肝汤, 酸敏感离子通道, 抗N-甲基-D-天冬氨酸受体

Abstract:

Objective To explore the therapeutic mechanism of Chaihu Shugan (CHSG) Decoction for improving cognitive impairment in rats with epilepsy induced by lithium chloride and pilocarpine. Methods Male SD rat models of cognitive impairment model after epilepsy induced by intraperitoneal injection with lithium chloride and pilocarpine were randomly divided into 5 groups (n=12) for treatment with daily gavage of saline, donepezil (90 mg/kg), or CHSG Decoction at 2.5, 5.0, 10, 20 and 40 g/kg for 4 consecutive weeks, with 10 rats with intraperitoneal injection with saline as the blank control group. Morris water maze test was used to evaluate cognitive and behavioral changes of the rats after treatment. The mRNA and protein expressions of ASIC1, NR1, NR2A and NR2B in the hippocampus of rats were detected using RT-qPCR and Western blotting. Results Compared with those with saline treatment, the rat models treated with CHSG Decoction at 5 and 10 g/kg showed significantly shortened escape latency and prolonged stay in the target quadrant with increased number of platform crossings in Morris water maze test. CHSG Decoction treatment at the two doses significantly increased ASIC1, NR1, NR2A and NR2B protein expressions in the hippocampus of the rat models, and their mRNA expression levels were all increased significantly after the treatment at the doses above 2.5 g/kg. Conclusion CHSG Decoction can improve cognitive impairment in rats after epilepsy possibly by regulating the expression and channel activity of NMDAR protein and its subunit protein via upregulating ASIC1 to modulate neuronal excitability and synaptic plasticity in the hippocampus.

Key words: epilepsy, cognitive impairment, treatment from Gan, Chaihu Shugan Decoction, acid sensitive ion channel, NMDAR